Denis Schrier, PhD

Denis Schrier, PhD has extensive work experience in the pharmaceutical industry, with a focus on toxicology and pharmacology.

From 2018 onwards, they have been working at Inozyme Pharma as the Vice President of Toxicology. Prior to that, they worked at CLAD Preclinical Development, LLC starting from 2016, where they served as a Principal Scientist, providing consulting support to companies in pharmaceutical development.

Before joining CLAD, Denis worked at Alexion Pharmaceuticals from 2012 to 2016, holding the position of Executive Director of Non Clinical Pharma/Toxicology. From 2005 to 2011, Denis Schrier was the Senior Director of Preclinical Development at Stryker Regenerative Medicine, where they were responsible for various aspects of pharmacology and toxicology research.

Denis Schrier's career started at Pfizer R&D in 1982, where they held multiple roles over a span of 23 years. These roles included serving as a Senior Research Fellow and Director, supervising teams and managing the preclinical discovery process.

Overall, Denis Schrier, PhD has a strong background in toxicology, pharmacology, and preclinical development in the pharmaceutical industry.

Denis Schrier, PhD, completed their Bachelor of Arts degree in Biology at Calvin University from 1973 to 1977. Subsequently, they pursued their PhD in Pathology at the Medical College of Wisconsin from 1977 to 1980.